Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

did not reach statistical significancep>0.051.0× alphaplainly factual
showed a trendp>0.051.0× alpha
It is worth noting that although the box plots of some genes (such as PDGFD) showed a trend of differences between groups, these differences did not reach statistical significance (p>0.05), possibly due to the limitation of sample size (only 29 samples in each group) and the high variability (standard deviation >50%) of IC50 values for some drugs.
showed a trendP<0.051.0× alpha
Relative Expression of Genes in the Intestine With regard to antioxidant genes, the relative expression of nuclear factor erythroid 2-related factor 2 (Nrf2) showed a trend of increasing first and then decreasing with the addition levels of TB in feed, and the highest levels was observed in 0.06% TB supplementation in feed ( P<0.05 ), however, the relative expression of Kelch-like ECH-associated protein 1 (Keap1) showed an opposite trend with Nrf2.
showed a trendp=.051.0× alpha
In this study, only prolonged hospitalisation showed a trend toward association with CPE carriage ( p=.05 ) Antibiotic Resistance Pattern of ESBL-PE and CPE ESBL-PE showed variable antibiotic resistance to gentamicin (19.4%-100 %) and amoxicillin/clavulanic acid (11.1%–100%).
showed a trendp < 0.051.0× alpha
Accordingly, the analysis of the glucagon/insulin ratio in all groups tested showed a trend to increase with respect to the corresponding ratio observed at 0 min; this increase was statistically significant after 60 min ( p < 0.05) of 100 mg/Kg D-Pinitol ( Figure 2 A) dose, and after 120 min ( p < 0.05) of 500 mg/Kg dose of D-Pinitol ( Figure 2 B).
showed a trendp = 0.051.0× alpha
Of those VIP-expressing neurons, Nlgn3 mRNA expression levels showed a trend to increase in mutant mice compared to WT (27.1 ± 1.1 versus 30.4 ± 1.2 mRNA copies per cell; n = 623 and 449 cells; WT and mutant mice respectively; p = 0.05; t = 1.9, df = 1070 Figure 6 (C10)). 3.5.1.
showed a trendP = .051.0× alpha
Mortality Compared to the control group, FCM administration showed a trend towards reduced risk of all-cause death (RR: 0.86, 95% CI: 0.74–1.00, P = .05, Figure 4A ) (absolute risk difference 16 (95% CI 29 to 0) fewer per 1000 patients; moderate certainty) and CV death (RR: 0.86, 95% CI: 0.72–1.02, P = .09, Figure 4B ) (absolute risk difference 12 (95% CI 24 fewer to 2 more) per 1000 patients; moderate certainty) at 1-year follow-up.